NanoMosaic develops nano-scale needles for analyzing proteins, nucleic acids, and other biomolecules. The company utilizes nanoneedle technology for multi-omic analysis.

NanoMosaic

Next generation protein interrogation powered by nanoneedles, enabling early disease detection, prognostic monitoring and biomarker discovery on a single chip.

Pura Vida Investments

RA Capital Management

TigerGene

TIME BioVentures

Insight Partners

NanoMosaic Inc.

🌟 𝐃𝐨𝐧’𝐭 𝐌𝐢𝐬𝐬 𝐎𝐮𝐫 𝐀𝐮𝐠𝐮𝐬𝐭 𝐒𝐞𝐬𝐬𝐢𝐨𝐧𝐬!  🌟​
Join us to discover Tessie, our all-in-one transgene and capsid characterization platform.​

🔬 𝐂𝐨𝐧𝐜𝐞𝐩𝐭? An exclusive session for your team to discover NanoMosaic’s groundbreaking instrument at the forefront of transforming gene therapy research. In 30 minutes, explore Tessie’s nanoneedle technology, dive into a complete workflow, and meet our experts.

🍴 𝐁𝐨𝐧𝐮𝐬? We'll provide lunch for your team during the session!

Reserve a spot for your team today: https://lnkd.in/eCjJFWg9

We're #hiring a new Accounting Clerk in Waltham, Massachusetts. Apply today or share this post with your network.

Looking for an amazing opportunity at an amazing company doing amazing things?  I have just the thing for you!  Join us in revolutionizing proteomics, multi-omics and so much more!

Leadership Evolution at NanoMosaic: The Company Welcomes Philippe Mourere as CEO, John Boyce Assumes the Role of Executive Chairman, and Appoints Joe Wilkinson as President and COO

[WEBINAR] Join us with our hosts Genetic Engineering & Biotechnology News on Tuesday, March 26 to learn how our Tessie platform detects and characterizes AAV capsids as well as full, empty, partial, and internally deleted transgenes directly from crude extracts. Learn more and register here: https://lnkd.in/exBYYHve

NANO

COM:NANOMOSAICLLC

NanoMosaic